162 related articles for article (PubMed ID: 3123720)
1. The value of mammography screening in women under age 50 years.
Eddy DM; Hasselblad V; McGivney W; Hendee W
JAMA; 1988 Mar; 259(10):1512-9. PubMed ID: 3123720
[TBL] [Abstract][Full Text] [Related]
2. Ten-year risk of false positive screening mammograms and clinical breast examinations.
Elmore JG; Barton MB; Moceri VM; Polk S; Arena PJ; Fletcher SW
N Engl J Med; 1998 Apr; 338(16):1089-96. PubMed ID: 9545356
[TBL] [Abstract][Full Text] [Related]
3. Screening for breast cancer.
Eddy DM
Ann Intern Med; 1989 Sep; 111(5):389-99. PubMed ID: 2504094
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
[TBL] [Abstract][Full Text] [Related]
7. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
Shen Y; Parmigiani G
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
[TBL] [Abstract][Full Text] [Related]
8. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
US Preventive Services Task Force
Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
[TBL] [Abstract][Full Text] [Related]
9. The effect of service screening on breast cancer mortality rates.
Cox B
Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
[TBL] [Abstract][Full Text] [Related]
10. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of mammographic screening strategies.
Lindfors KK; Rosenquist CJ
JAMA; 1995 Sep; 274(11):881-4. PubMed ID: 7674501
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of aggressive breast cancer screening.
Moskowitz M; Fox SH
Radiology; 1979 Jan; 130(1):253-6. PubMed ID: 103136
[TBL] [Abstract][Full Text] [Related]
13. Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models.
Obdeijn IM; Heijnsdijk EA; Hunink MG; Tilanus-Linthorst MM; de Koning HJ
Eur J Cancer; 2016 Aug; 63():135-42. PubMed ID: 27318001
[TBL] [Abstract][Full Text] [Related]
14. Impact of a mailed intervention on annual mammography and physician breast examinations among women at high risk of breast cancer.
Richardson JL; Mondrus GT; Danley K; Deapen D; Mack T
Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):71-6. PubMed ID: 8770470
[TBL] [Abstract][Full Text] [Related]
15. Mammographic screening for breast cancer: An invited review of the benefits and costs.
Greif JM
Breast; 2010 Aug; 19(4):268-72. PubMed ID: 20371181
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer screening for women aged 40 to 49 years--what does the evidence mean for New Zealand?
Baker S; Wall M; Bloomfield A
N Z Med J; 2005 Aug; 118(1221):U1628. PubMed ID: 16138166
[TBL] [Abstract][Full Text] [Related]
17. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
[TBL] [Abstract][Full Text] [Related]
18. Screening for breast cancer in England: past and future.
Advisory Committee on Breast Cancer Screening
J Med Screen; 2006; 13(2):59-61. PubMed ID: 16792825
[TBL] [Abstract][Full Text] [Related]
19. Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI.
Feig S
Obstet Gynecol Clin North Am; 2011 Mar; 38(1):179-96, ix. PubMed ID: 21419333
[TBL] [Abstract][Full Text] [Related]
20. United States Preventive Services Task Force screening mammography recommendations: science ignored.
Hendrick RE; Helvie MA
AJR Am J Roentgenol; 2011 Feb; 196(2):W112-6. PubMed ID: 21257850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
